FDA Approves AstraZeneca’s Imjudo for Combination Liver Cancer Treatment October 26, 2022 AutoBot News 0 AstraZeneca’s Imjudo (tremelimumab) was approved by FDA in combination with Imfinzi (durvalumab) for treating unresectable liver cancer.
